PATENT CLAIM ANALYSIS

Application Number: 16080617
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-03
Patent Classification: ["424", "174100"]

Abstract:
This invention provides a method that combines a checkpoint inhibitor and a glucocorticoid receptor modulator to treat cancer, e.g., a checkpoint inhibitor sensitive cancer.

Claim (Index 13):
The method of  claim 1  wherein the cancer is a GR +  cancer and wherein the cancer is selected from the group consisting of breast cancer, prostate cancer, Melanoma, Sarcoma, Renal cell cancer, Head and Neck cancer, Hepatocellular cancer, Glioblastoma, Cervical cancer, neuroendocrine cancer, Bladder cancer, Prostate cancer, Esophageal cancer, mesothelioma, Lung cancer, Ovarian cancer, Pancreas cancer, Gall bladder cancer, Gastric cancer, Endometrial cancer, and colon cancer.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 96.0
- Lexical Diversity: 1.35
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15942312', '15697878', '15915477', '15500618', '15809759']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7602195867016232
- 35 USC 102 Novelty (BERT): 0.5198820979605598
- Combined Prediction Score: 0.7361858378275169
- Mean Citation Score: 297.060654
- Max Citation Score: 317.0144
- Similarity Product: 259.1958333402634

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test